Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Nov 26, 2014 4:27pm
448 Views
Post# 23167455

RE:RE:RE:US market close tomorrow

RE:RE:RE:US market close tomorrowWittman,

perhaps I missed a post where someone was questioning mgmt credibility ?  I certainly am not questioning credibility, I just think they have been wrong in their approach.  That doesnt make them non-credible.

The fact is,  they have been exceptional executing on the things that they need to be exceptiona at to make this company special....ie:  developing their pipleline and the inherent value of their portfolio of offerings.  The diversity in what they have created is unlike anything I have seen in a small cap stock, nevermind a small cap cdn biotech.

Lets not beleagure the point,  I just simply think they have done a poor job at forecasting, and perhaps even partially been poor at actual dealmaking that would deliver the revenues they have expected. And candidly THAT has hurt credibility.   But it doesnt change the fact that the value is there to sell / license whatever... and that stuff arguably gets more credible by the day... and I would suggest that is what is by far the most important.
Bullboard Posts